Additionally, gain‐of‐function mutations in NLRP3 cause a spectrum of cryopyrin‐associated periodic syndromes (CAPS) characterized by systemic inflammation (Hoffman et al., 2001). Here, NLRP3 is linked to cryopyrin-associated periodic syndrome.